CAS 1883510-31-3

ML327

CAS : 1883510-31-3

Formule : C₁₉H₁₈N₄O₄

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 366.3706

Ref: IN-DA01EB2B

ML327

CAS : 1883510-31-3

ML327

Degré de pureté : ≥98%

Masse moléculaire : 366.37g/mol

Ref: 54-BUP05086

ML327

CAS : 1883510-31-3

ML327 is a MYC blocker. ML327 can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition (EMT).

Formule : C₁₉H₁₈N₄O₄

Degré de pureté : 98.47%

Couleur et forme : Solid

Masse moléculaire : 366.37

Ref: TM-T4252

ML327

CAS : 1883510-31-3

ML327 is a small molecule that has been shown to inhibit the growth of cancer cells in the mesial, lingually, and distal regions of the tongue. It also inhibits choroidal neovascularization (CNV) in mouse models. ML327 is a chemical entity that belongs to the class of protein synthesis inhibitors. It targets the protein synthesis machinery by binding to ribosomes and inhibiting translation. ML327 also binds to TNF-related apoptosis-inducing ligand (TRAIL) receptors and induces TRAIL-mediated apoptosis in cancer cells.

Formule : C₁₉H₁₈N₄O₄

Degré de pureté : Min. 95%

Masse moléculaire : 366.37 g/mol

Ref: 3D-IAD51031